Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced/ Metastatic Renal Cell Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01444807
What this trial is testing

Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases

Who this might be right for
Metastatic Renal Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 132
Early research (Phase 1)UnknownNCT05420519
What this trial is testing

Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer

Who this might be right for
Metastatic TumorRenal Cell CarcinomaAdvanced Cancer
Chongqing Precision Biotech Co., Ltd 24
Testing effectiveness (Phase 2)WithdrawnNCT00003714
What this trial is testing

Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer

Who this might be right for
Liver CancerMetastatic Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01538238
What this trial is testing

Pazopanib_NCRCC,Ph2 STUDY

Who this might be right for
Locally Advanced or Metastatic Non-clear Cell Type Renal Cell Carcinoma
Samsung Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT00017329
What this trial is testing

PS-341 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00098943
What this trial is testing

NGR-TNF in Treating Patients With Advanced Solid Tumors

Who this might be right for
Colorectal CancerHead and Neck CancerKidney Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC 70
Testing effectiveness (Phase 2)Ended earlyNCT03875313
What this trial is testing

Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaTNBC - Triple-Negative Breast Cancer+4 more
Calithera Biosciences, Inc 33
Testing effectiveness (Phase 2)Study completedNCT01829841
What this trial is testing

Famitinib in Patients With Advanced Metastatic Renal Cell Cancer

Who this might be right for
Renal Cell CancerMetastatic Renal Cell Cancer
Jiangsu HengRui Medicine Co., Ltd. 150
Early research (Phase 1)UnknownNCT05468190
What this trial is testing

A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more
Chongqing Precision Biotech Co., Ltd 48
Testing effectiveness (Phase 2)Study completedNCT00378703
What this trial is testing

Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7
National Cancer Institute (NCI) 361
Early research (Phase 1)Ended earlyNCT03483883
What this trial is testing

Avelumab/Gemcitabine in Sarcomatoid RCC

Who this might be right for
Metastatic sRCC
Abramson Cancer Center at Penn Medicine 6
Testing effectiveness (Phase 2)UnknownNCT06221774
What this trial is testing

Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors

Who this might be right for
Clear Cell Renal CarcinomaUrothelial CarcinomaMetastatic Castration-resistant Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 42
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Early research (Phase 1)WithdrawnNCT03189186
What this trial is testing

Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas

Who this might be right for
Renal Cell CarcinomaMetastatic Kidney Cancer
University of California, Irvine
Early research (Phase 1)Study completedNCT00351949
What this trial is testing

IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)

Who this might be right for
Stage IV Renal Cell Carcinoma
Immutep S.A.S. 24
Early research (Phase 1)Ended earlyNCT05355753
What this trial is testing

Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors

Who this might be right for
Synovial SarcomaSoft Tissue Sarcoma
C4 Therapeutics, Inc. 49
Testing effectiveness (Phase 2)Study completedNCT00077129
What this trial is testing

Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer

Who this might be right for
Kidney Cancer
Eastern Cooperative Oncology Group 22
Testing effectiveness (Phase 2)UnknownNCT00293501
What this trial is testing

Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney Cancer
University of Vermont 35
Testing effectiveness (Phase 2)Study completedNCT00310011
What this trial is testing

Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Wake Forest University Health Sciences 71
Testing effectiveness (Phase 2)Ended earlyNCT03829501
What this trial is testing

A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies

Who this might be right for
Squamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Kymab Limited 222
Next Page